微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 39.67% | -0.87% | 11.27% | 25/52 | 36.42% | 诺泰生物 | 69.32% | 行业排名> |
| 2024-06-30 | 35.65% | -4.39% | 27.15% | 31/52 | 36.51% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 28.04% | -14.3% | -34.47% | 36/52 | 36.38% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 42.79% | 24.26% | 6.91% | 19/52 | 38.59% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 40.02% | 25.62% | 7.32% | 30/52 | 40.29% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 37.29% | 90.44% | 13.97% | 34/52 | 40.13% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 32.72% | 149.94% | -4.98% | 40/52 | 39.27% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 34.44% | -12.72% | 8.09% | 41/52 | 40.44% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 31.86% | -8.78% | 62.7% | 38/52 | 41.37% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 19.58% | -31.73% | 49.57% | 47/52 | 40.21% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 13.09% | -17.93% | -66.82% | 41/52 | 38.93% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 39.46% | 6.26% | 12.98% | 33/52 | 42.21% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 34.92% | 20.72% | 21.76% | 31/52 | 43.4% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 28.68% | 536.91% | 79.82% | 41/52 | 42.88% | 南华生物 | 83.19% | 行业排名> |
| 2021-03-31 | 15.95% | 132% | -57.04% | 31/52 | 40.06% | 南华生物 | 83.9% | 行业排名> |
| 2020-12-31 | 37.13% | -15.24% | 28.35% | 39/52 | 38.9% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 28.93% | -30.23% | 542.43% | 28/52 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 4.5% | -87.36% | 109.03% | 38/52 | 39.73% | 南华生物 | 78.74% | 行业排名> |
| 2020-03-31 | -49.85% | -345.32% | -213.79% | 32/52 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 43.81% | -7.89% | 5.65% | 22/52 | 43.15% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 41.47% | -10.51% | 16.42% | 17/52 | 44.93% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 35.62% | -20.25% | 75.28% | 27/52 | 45.53% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 20.32% | -35.72% | -57.27% | 29/52 | 43.89% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 47.56% | 1.47% | 2.64% | 12/52 | 42.47% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 46.34% | 5.92% | 3.75% | 12/52 | 44.34% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 44.66% | 10.6% | 41.27% | 18/52 | 44.61% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 31.61% | 43.18% | -32.55% | 25/52 | 46.34% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 46.87% | 3.19% | 7.14% | 12/52 | 41.42% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 43.75% | -0.49% | 8.34% | 12/52 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 40.38% | 6.16% | 82.89% | 19/52 | 43.99% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 22.08% | 224.66% | -51.39% | 19/52 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 45.42% | -5.27% | 3.33% | 13/52 | 40.69% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 43.96% | 2.42% | 15.58% | 7/52 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 38.04% | -0.68% | 459.29% | 13/52 | 32.79% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 6.8% | 314.28% | -85.82% | 18/52 | 28.42% | 盈康生命 | 75.69% | 行业排名> |
| 2015-12-31 | 47.95% | -0.78% | 11.72% | 8/52 | 37.17% | 海特生物 | 95.38% | 行业排名> |
| 2015-09-30 | 42.92% | 0.44% | 12.08% | 8/52 | 33.25% | 药石科技 | 67.7% | 行业排名> |
| 2015-06-30 | 38.3% | 120.25% | 1306.61% | 9/52 | 32.07% | 药石科技 | 66.33% | 行业排名> |
| 2015-03-31 | -3.17% | -117.34% | -106.57% | 19/52 | 24.2% | 睿智医药 | 52.68% | 行业排名> |
| 2014-12-31 | 48.33% | 172.75% | 13.1% | 5/52 | 35.91% | 海特生物 | 95.14% | 行业排名> |
| 2014-09-30 | 42.73% | 131.1% | 145.77% | 7/52 | 31.52% | 皓宸医疗 | 52.16% | 行业排名> |
| 2014-06-30 | 17.39% | 7.78% | -4.99% | 16/52 | 30.64% | 皓宸医疗 | 55.65% | 行业排名> |
| 2014-03-31 | 18.3% | 23.88% | 3.28% | 14/52 | 31.6% | 新里程 | 53.57% | 行业排名> |